3,5-Difluoromethcathinone
3,5-Difluoromethcathinone[edit]

3,5-Difluoromethcathinone (also known as 3,5-DFMC) is a synthetic stimulant of the cathinone class. It is a designer drug that has been sold online as a "research chemical". The compound is structurally related to other synthetic cathinones such as mephedrone and methcathinone.
Chemical Structure and Properties[edit]
3,5-Difluoromethcathinone is characterized by the presence of two fluorine atoms at the 3 and 5 positions of the phenyl ring. This modification is believed to influence the compound's pharmacological properties, potentially altering its potency and duration of action compared to other cathinones.
The chemical formula of 3,5-DFMC is C10H11F2NO, and it has a molecular weight of 199.20 g/mol. The presence of fluorine atoms can increase the lipophilicity of the molecule, which may affect its ability to cross the blood-brain barrier.
Pharmacology[edit]
As a member of the cathinone class, 3,5-DFMC is expected to act as a central nervous system stimulant. Cathinones typically function by increasing the levels of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. This is achieved through the inhibition of their reuptake or by promoting their release.
The specific pharmacological profile of 3,5-DFMC has not been extensively studied, but it is likely to share similarities with other fluorinated cathinones, which are known to have stimulant and empathogenic effects.
Legal Status[edit]
The legal status of 3,5-Difluoromethcathinone varies by country. In many jurisdictions, it may be considered a controlled substance due to its structural similarity to other banned cathinones. It is important for researchers and users to be aware of the legal implications of possessing or distributing this compound.
Health Risks and Safety[edit]
The health risks associated with 3,5-DFMC are not well-documented, but it is likely to pose similar risks to other synthetic cathinones. These can include cardiovascular issues, neurological effects, and potential for addiction. Users may experience increased heart rate, elevated blood pressure, and anxiety.
Due to the lack of comprehensive studies, the long-term effects of 3,5-DFMC use are unknown. As with other designer drugs, there is a risk of adverse reactions and toxicity, especially when used in combination with other substances.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian